2022, Heart Failure and Innovation - Cardiovascular Update

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

DAIC

MAY 6, 2024

We are committed to protecting the future commercial value of our innovative PH-HFpEF treatment,” said Chris Giordano , President & Chief Executive Officer of Tenax Therapeutics. Getty Images milla1cf Mon, 05/06/2024 - 10:48 May 6, 2024 — Tenax Therapeutics, Inc. ,

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Pulmonary Hypertension

Allina Health’s Abbott Northwestern Hospital is First in Minnesota to Implant Barostim Therapy to Improve Symptoms of Heart Failure

DAIC

FEBRUARY 12, 2024

Barostim is the world’s first FDA-approved neuromodulation heart failure device, which works by stimulating baroreceptors — natural sensors located in the wall of the carotid artery, according to CVRx. In November, 2022, the company launched its new Barostim NEO2 IPG. and Allina Health. and Allina Health. and Allina Health.

Heart Failure

Heart Failure Hospital Quality of Life Heart Attack

Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis

DAIC

JANUARY 15, 2024

Cardiac amyloidosis is a heterogeneous disease that results from the accumulation of abnormal proteins within the heart, impairing its ability to pump blood. Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heart failure, which can have dire outcomes if not found early.

Ultrasound

Ultrasound Coronary Artery Disease Innovation Heart Failure

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Allina Health Minneapolis Heart Institute is First in Minnesota to Implant Barostim Therapy to Improve Symptoms of Heart Failure

DAIC

FEBRUARY 12, 2024

A team at Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital has successfully completed the first Barostim Baroreflex Activation Therapy implant in the state of Minnesota, according to an announcement from CVRx, Inc. In November, 2022, the company launched its new Barostim NEO2 IPG. and Allina Health.

Heart Failure

Heart Failure Hospital Quality of Life Heart Attack

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

FEBRUARY 29, 2024

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.

Aortic valve

Aortic valve Myocardial Infarction Aortic Blood Pressure

Learning some crucial cardiovascular hemodynamic lessons* from Giraffe

Dr. S. Venkatesan MD

JULY 1, 2024

The innovators and engineers of new-age mechanical assist systems could learn a few crucial insights from these unique and humble animal beings. Epub 2022 Jul 25. If the ventricles assume a tubular morphology, optimal energy and cardiac power can be accrued. Batisda procedure etc) 3. Aalkjær C, Wang T. J Muscle Res Cell Motil.

Cardiomyopathy

Cardiomyopathy Aortic valve Aortic Blood Pressure

FDA Clears First AI to Aid Heart Failure Detection During Routine Check-ups

DAIC

APRIL 3, 2024

healthcare providers can now detect Low EF, a key heart failure indicator, in 15 seconds using an Eko stethoscope during a routine physical examination. This leap in early detection marks both a significant medical innovation and a new era in the detection of cardiovascular disease. Heart failure. In the U.S.,

Heart Failure

Heart Failure Cardiomyopathy AFIB Hospital

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

APRIL 23, 2024

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body.

Aortic valve

Aortic valve Aortic Innovation Cardiothoracic

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

JUNE 13, 2024

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body.

Aortic valve

Aortic valve Aortic Innovation Cardiothoracic

iRhythm Unveils New Data Demonstrating Benefits of Long-Term Continuous Monitoring for Arrhythmia Detection

DAIC

MARCH 31, 2025

These findings challenge the long-held assumption that frequent symptoms justify short-duration monitoring, said Mintu Turakhia, MD, iRhythm Chief Medical and Scientific Officer and EVP of Product Innovation. If left untreated, certain arrhythmias can damage the heart, brain, or other organs 4 and increase the risk of stroke or death.

Arrhythmia

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure

New Data for Medtronic CoreValve/Evolut TAVR Systems Reinforces Excellent Valve Performance

DAIC

JUNE 7, 2024

We know how important valve performance and durability are when clinicians are seeking a TAVR product that is not only safe, but also reduces the risk of rehospitalization and mortality,” said Nina Goodheart, senior vice president and president of the Structural Heart & Aortic business, which is part of the Cardiovascular portfolio at Medtronic. “We

TAVR

TAVR Aortic valve Aortic Stenosis

Research landscape of genetics in dilated cardiomyopathy: insight from a bibliometric analysis

Frontiers in Cardiovascular Medicine

JULY 11, 2024

The co-occurrence of keywords has generated 8 clusters, including DCM, lamin a/c, heart failure, sudden cardiac death, hypertrophic cardiomyopathy, cardiac hypertrophy, arrhythmogenic cardiomyopathy, and next-generation sequencing.

Cardiomyopathy

Cardiomyopathy Research Sudden Cardiac Death Document

Why ICDs are less effective in Non Ischemic DCM ?

Dr. S. Venkatesan MD

FEBRUARY 20, 2024

SCD is the leading cause of mortality in heart failure. Still, Mirowski”s electrical kid survived the test of time and evolved with great technological innovations from companies like Medtronic, Guidant, Abbot etc. It has, now grown into 45 year old wonder device , that can wake up the heart from death. Circulation.

Defibrillator

Defibrillator Heart Failure Sudden Cardiac Death Cardiomyopathy

The legal case – naming a few names

Dr. Malcolm Kendrick

OCTOBER 30, 2024

2022-25) Swiss Reinsurance Company: £645K China Kadoorie Biobank (2002-ongoing) AstraZeneca: $300K Bayer AG: £300K GlaxoSmithKline: £3.6M plus drug supply SHARP trial of simvasatin/ezetimibe (2002-2013) Merck/Schering: £40M plus drug supply SHARP3 (2022-23) Boehringer Ingelheim: £1.8M plus drug supply Bayer: £1.8M

Cholesterol

Cholesterol Article Research Diet

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

Allina Health’s Abbott Northwestern Hospital is First in Minnesota to Implant Barostim Therapy to Improve Symptoms of Heart Failure

Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis

Webinars

Allina Health Minneapolis Heart Institute is First in Minnesota to Implant Barostim Therapy to Improve Symptoms of Heart Failure

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

Learning some crucial cardiovascular hemodynamic lessons* from Giraffe

FDA Clears First AI to Aid Heart Failure Detection During Routine Check-ups

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

iRhythm Unveils New Data Demonstrating Benefits of Long-Term Continuous Monitoring for Arrhythmia Detection

New Data for Medtronic CoreValve/Evolut TAVR Systems Reinforces Excellent Valve Performance

Research landscape of genetics in dilated cardiomyopathy: insight from a bibliometric analysis

Why ICDs are less effective in Non Ischemic DCM ?

The legal case – naming a few names

Stay Connected